The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option ...

as second-line treatment of endogenous hypercortisolemia in adults with Cushing syndrome. Endogenous Cushing syndrome is a condition of excess cortisol that can result in complications such as ...

This aim of this review is to analyze and present the available options for medical management of Cushing's syndrome as well as review potential new therapies and their role in the treatment of ...

New research has increased knowledge about how best to manage equines with Cushing’s syndrome — for which ... once after four weeks of pergolide treatment and once without pergolide treatment.

The key objective of this PPID study is to understand genetic variants that contribute to the effectiveness and adverse ...

Dr Randhir Singh Hypertension, commonly known as high blood pressure, is a prevalent health concern associated with humans, ...

Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.

Endocrine disorders that can cause a sudden onset of warmth and redness include Cushing syndrome ... on its symptoms and your medical history. Treatment for rosacea involves medications, avoidance ...

Discover the different forms of hypertension, their causes, risks, and treatments to prevent long-term organ damage.

Corcept Therapeutics Inc. (NASDAQ:CORT) discovers and develops medications for the treatment of severe endocrinologic, ...